Characterizing proteins of unknown function: Orphan cytochrome P450 enzymes as a paradigm

Molecular Interventions

Volumn 10, Issue 3, 2010, Pages 153-163

  Guengerich, F Peter ^a   Tang, Zhongmei ^a   Salamanca Pinzón, S Giovanna ^a   Cheng, Qian ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

16ALPHA CYANOPREGNENOLONE; ANANDAMIDE; ANTIBIOTIC AGENT; CODEINE; CYTOCHROME; CYTOCHROME P450; CYTOCHROME P450 154A1; CYTOCHROME P450 2D6; CYTOCHROME P450 3A; CYTOCHROME P450 3A4; DUTASTERIDE; ERGOT ALKALOID; FINASTERIDE; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; LYSERGIC ACID; MORPHINE; MORPHINONE; ORIPAVINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; STEROID 5ALPHA REDUCTASE; THEBAINE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARABIDOPSIS; DRUG STRUCTURE; DRUG SYNTHESIS; FUNCTIONAL PROTEOMICS; GENE FUNCTION; GENE SEQUENCE; HUMAN; METABOLOMICS; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PSEUDOHERMAPHRODITISM; REVIEW; RICE; STREPTOMYCES; STRUCTURE ANALYSIS;

BACTERIAL PROTEINS; CYTOCHROME P-450 ENZYME SYSTEM; GENOMICS; HUMANS; METABOLOMICS; PROTEOMICS; STREPTOMYCES;

EID: 77953512029     PISSN: 15340384     EISSN: 15432548     Source Type: Journal    
DOI: 10.1124/mi.10.3.6     Document Type: Review

References (88)

1. Hanson AD, Pribat A, Waller JC, and Crecy-Lagard V (2010) "Unknown" proteins and "orphan" enzymes: The missing half of the engineering parts list-and how to find it Biochem J 425:1-11.
2. Beato, M (1989) Gene regulation by steroid hormones. Cell 56:335-344.
3. Yamamoto KR (1985) Steroid receptor regulated transcription of specific genes and gene networks. Annu Rev Genet 19:209-252.
4. Arriza JL, Weinberger C, Cerelli G, Glaser TM, Handelin BL, Housman DE, and Evans RM (1987) Cloning of human mineralocorticoid receptor complementary DNA: Structural and functional kinship with the glucocorticoid receptor. Science 237:268-275. (Pubitemid 17095145)
5. Berg JM (1989) DNA binding specificity of steroid receptors. Cell 57:1065-1068.
6. Evans RM (1988) The steroid and thyroid hormone receptor superfamily. Science 240:889-895.
7. Issemann I and Green S (1990) Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347:645-650. (Pubitemid 120028995)
8. Kliewer SA, Moore JT, Wade L, Staudinger JL, Watson MA, Jones SA, McKee DD, Oliver BB, Wilson TM, Zetterstörm RH, et al. (1998) An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell 92:73-82. (Pubitemid 28053299)
9. Honkakoski P, Zelko I, Sueyoshi T, and Negishi M (1998) The nuclear orphan receptor CAR-RXR heterodimer activates the phenobarbitalresponsive enhancer module of the CYP2B gene. Mol Cell Biol 18:1-7.
10. Wrighton SA, Brian WR, Sari MA, Iwasaki M, Guengerich FP, Raucy JL, Molowa DT, and VandenBranden, M (1990) Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3). Mol Pharmacol 38:207-213. (Pubitemid 20255306)
11. Jencks WP (1969) Catalysis in Chemistry and Enzymology. McGraw-Hill, New York.
12. Gerlt JA and Babbitt PC (2001) Divergent evolution of enzymatic function: mechanistically diverse superfamilies and functionally distinct suprafamilies. Annu Rev Biochem 70:209-246.
13. rd Ed. (Ortiz de Montellano PR, ed) pp. 87-114, Kluwer Academic/Plenum Publishers, New York.
14. Ekroos M and Sjögren T (2006) Structural basis for ligand promiscuity in cytochrome P450 3A4. Proc Natl Acad Sci USA 103:13682-13687.
15. Andersson S, Bishop RW, and Russell DW (1989) Expression cloning and regulation of steroid 5α-reductase, an enzyme essential for male sexual differentiation. J Biol Chem 264:16249-16255. (Pubitemid 19238390)
16. Andersson S and Russell DW (1990) Structural and biochemical properties of cloned and expressed human and rat steroid 5α-reductases. Proc Natl Acad Sci USA 87:3640-3644. (Pubitemid 120015725)
17. Frye SV (2006) Discovery and clinical development of dutasteride, a potent dual 5α-reductase inhibitor. Curr Top Med Chem 6:405-421.
18. Montgomery MK, Xu S, and Fire A (1998) RNA as a target of double-stranded RNA-mediated genetic interference in Caenorhabditis elegans. Proc Natl Acad Sci USA 95:15502-15507. (Pubitemid 29018728)
19. McCaffrey AP, Meuse L, Pham TT, Conklin DS, Hannon GJ, and Kay MA (2002) RNA interference in adult mice. Nature 418:38-39.
20. Vidalin O, Muslmani M, Estienne C, Echchakir H, and Abina AM (2009) In vivo target validation using gene invalidation, RNA interference and protein functional knockout models: It is the time to combine. Curr Opin Pharmacol 9:669-676.
21. Yuan X, Ta TC, Lin M, Evans JR, Dong Y, Bolotin E, Sherman MA, Forman BM, and Sladek FM (2009) Identification of an endogenous ligand bound to a native orphan nuclear receptor. PloS One 4:e5609.
22. Fersht A (1999) Structure and Mechanism in Protein Science, pp. 158-159, Freeman, New York.
23. Saghatelian A and Cravatt BF (2005) Assignment of protein function in the postgenomic era. Nat Chem Biol 1:130-142.
24. Barglow KT and Cravatt BF (2007) Activity-based protein profiling for the functional annotation of enzymes. Nat Methods 4:822-827.
25. Wright AT, Song JD, and Cravatt BF (2009) A suite of activity-based probes for human cytochrome P450 enzymes. J Am Chem Soc 131:10692-10700.
26. Katajamaa M and Oresic M (2005) Processing methods for differential analysis of LC/MS profile data. BMC Bioinformatics 6:179.
27. Smilde AK, van der Werf MJ, Bijlsma S, van der Werff-van der Vat BJ, and Jellema RH (2005) Fusion of mass spectrometry-based metabolomics data. Anal Chem 77:6729-6736.
28. Katajamaa M, Miettinen J, and Oresic M (2006) MZmine: Toolbox for processing and visualization of mass spectrometry based molecular profile data. Bioinformatics (Oxford, UK) 22:634-636.
29. Lommen A (2009) MetAlign: interface-driven, versatile metabolomics tool for hyphenated full-scan mass spectrometry data preprocessing. Anal Chem 81:3079-3086.
30. Smith CA, Want EJ, O'Maille G, Abagyan R, and Siuzdak G (2006) XCMS: Processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal Chem 78:779-787.
31. Peters S, van Velzen E, and Janssen HG (2009) Parameter selection for peak alignment in chromatographic sample profiling: Objective quality indicators and use of control samples. Anal Bioanal Chem 394:1273-1281.
32. Sanchez-Ponce R and Guengerich FP (2007) Untargeted analysis of mass spectrometry data for elucidation of function of new enzymes. Anal Chem 79:3355-3362.
33. Tang Z, Martin MV, and Guengerich FP (2009) Elucidation of functions of human cytochrome P450 enzymes: Identification of endogenous substrates in tissue extracts by LC-MS metabolomics and isotopic labeling approaches. Anal Chem 81:3071-3078.
34. Haarmann T, Ortel I, Tudzynski P, and Keller U (2006) Identification of the cytochrome P450 monooxygenase that bridges the clavine and ergoline alkaloid pathways. Chembiochem 7:645-652.
35. Zhao B and Waterman MR (2007) Novel properties of P450s in Streptomyces coelicolor. Drug Metab Rev 39:343-352.
36. Chun Y-J, Shimada T, Sanchez-Ponce R, Martin MV, Lee L, Zhao B, Kelly SL, Waterman MR, Lamb DC, and Guengerich FP (2007) Electron transfer pathway for a streptomyces cytochrome P450. Cytochrome P450 105D5-catalyzed fatty acid hydroxylation in Streptomyces coelicolor A3(2). J Biol Chem 282:17486-17500.
37. Eberle D, Ullmann P, Werck-Reichhart D, and Petersen M (2009) cDNA cloning and functional characterisation of CYP98A14 and NADPH:cytochrome P450 reductase from Coleus blumei involved in rosmarinic acid biosynthesis. Plant Mol Biol 69:239-253.
38. rd Ed. (Ortiz de Montellano PR, ed) pp. 377-530, Kluwer Academic/Plenum Publishers, New York.
39. Morant M, Jorgensen K, Schaller H, Pinot F, Møller BL, Werck-Reichhart D, and Bak S (2007) CYP703 is an ancient cytochrome P450 in land plants catalyzing in-chain hydroxylation of lauric acid to provide building blocks for sporopollenin synthesis in pollen. Plant Cell 19:1473-1487.
40. Olry A, Schneider-Belhaddad F, Heintz D, and Werck-Reichhart D (2007) A medium-throughput screening assay to determine catalytic activities of oxygen-consuming enzymes:A new tool for functional characterization of cytochrome P450 and other oxygenases. Plant J 51:331-340.
41. Ehlting J, Provart NJ, and Werck-Reichhart D (2006) Functional annotation of the Arabidopsis P450 superfamily based on large-scale coexpression analysis. Biochem Soc Trans 34:1192-1198.
42. Ehlting J, Sauveplane V, Olry A, Ginglinger JF, Provart NJ, and Werck-Reichhart D (2008) An extensive (co-)expression analysis tool for the cytochrome P450 superfamily in Arabidopsis thaliana. BMC Plant Biol 8:47.
43. Ikezawa N, Iwasa K, and Sato F (2008) Molecular cloning and characterization of CYP80G2, a cytochrome P450 that catalyzes an intramolecular C-C phenol coupling of (S)-reticuline in magnoflorine biosynthesis, from cultured Coptis japonica cells. J Biol Chem 283:8810-8821.
44. Gesell A, Rolf M, Ziegler J, Diaz Chavez ML, Huang FC, and Kutchan TM (2009) CYP719B1 is salutaridine synthase, the C-C phenol-coupling enzyme of morphine biosynthesis in opium poppy. J Biol Chem 284:24432-24442.
45. Ikezawa N, Iwasa K, and Sato F (2009) CYP719A subfamily of cytochrome P450 oxygenases and isoquinoline alkaloid biosynthesis in Eschscholzia californica. Plant Cell Rep 28:123-133.
46. Yu AM, Idle JR, Herraiz T, Küpfer A, and Gonzalez FJ (2003) Screening for endogenous substrates reveals that CYP2D6 is a 5-methoxyindolethylamine O-demethylase. Pharmacogenetics 13:307-319.
47. Cheng JB, Motola DL, Mangelsdorf DJ, and Russell DW (2003) De-orphanization of cytochrome P450 2R1: A microsomal vitamin D 25-hydroxylase. J Biol Chem 278:38084-38093.
48. Niwa T, Murayama N, and Yamazaki H Oxidation of endobiotics mediated by xenobiotic-metabolizing forms of human cytochrome P450. Curr Drug Metab., in press.
49. Tang Z, Salamanca-Pinzón SG, Wu Z-L, Xiao Y, and Guengerich FP (2010) Human cytochrome P450 4F11: Heterologons expression in bacteria, purification, and characterization of catalytic function. Arch Biochem Biophys 494:86-93.
50. Weitz CJ, Faull KF, and Goldstein A (1987) Synthesis of the skeleton of the morphine molecule by mammalian liver. Nature 330:674-677.
51. Kodaira H and Spector S (1988) Transformation of thebaine to oripavine, codeine, and morphine by rat liver, kidney, and brain microsomes. Proc Natl Acad Sci USA 85:1267-1271. (Pubitemid 18073990)
52. Poeaknapo C, Schmidt J, Brandsch M, Drager B, and Zenk MH (2004) Endogenous formation of morphine in human cells. Proc Natl Acad Sci USA 101:14091-14096. (Pubitemid 39305035)
53. Grobe N, Zhang B, Fisinger U, Kutchan TM, Zenk MH, and Guengerich FP (2009) Mammalian cytochrome P450 enzymes catalyze the phenolcoupling step in endogenous morphine biosynthesis. J Biol Chem 284:24425-24431.
54. Dayer P, Desmeules J, Leemann T, and Striberni R (1988) Bioactivation of the narcotic drug codeine in human liver is mediated by the polymorphic monooxygenase catalyzing debrisoquine 4-hydroxylation. Biochem Biophys Res Commun 152:411-416.
55. Dhar M, Sepkovic DW, Hirani V, Magnusson RP, and Lasker JM (2008) Omega oxidation of 3-hydroxy fatty acids by the human CYP4F gene subfamily enzyme CYP4F11. J Lipid Res 49:612-624.
56. Chuang SS, Helvig C, Taimi M, Ramshaw HA, Collop AH, Amad M, White JA, Petkovich M, Jones G, and Korczak B (2004) CYP2U1, a novel human thymus- and brain-specific cytochrome P450, catalyzes ω-and (ω-1)-hydroxylation of fatty acids. J Biol Chem 279:6305-6314.
57. Karlgren M, Backlund M, Johansson I, Oscarson M, and Ingelman-Sundberg M (2004) Characterization and tissue distribution of a novel human cytochrome P450-CYP2U1. Biochem Biophys Res Commun 315:679-685.
58. Nakano M, Kelly EJ, and Rettie AE (2009) Expression and characterization of CYP4V2 as a fatty acid omega-hydroxylase. Drug Metab Dispos 37:2119-2122.
59. Stark K, Dostalek M, and Guengerich FP (2008) Expression and purification of orphan cytochrome P450 4X1 and oxidation of anandamide. FEBS J 275:3706-3717.
60. Zöllner A, Dragan CA, Pistorius D, Muller R, Bode HB, Peters FT, Maurer HH, and Bureik M (2009) Human CYP4Z1 catalyzes the in-chain hydroxylation of lauric acid and myristic acid. Biol Chem 390:313-317.
61. rd Ed. (Ortiz de Montellano, P.R., ed.) pp. 531-551, Kluwer Academic/Plenum Publishers, New York.
62. Lu AYH and Coon MJ (1968) Role of hemoprotein P-450 in fatty acid ω-hydroxylation in a soluble enzyme system from liver microsomes. J Biol Chem 243:1331-1332.
63. Jakoby WB (1980) Detoxication enzymes, in Enzymatic Basis of Detoxication, Vol. 1 (Jakoby WB, ed.) pp. 1-6, Academic Press, New York.
64. Gonzalez FJ and Kimura S (2003) Study of P450 function using gene knockout and transgenic mice. Arch Biochem Biophys 409:153-158.
65. Gu J, Weng Y, Zhang QY, Cui H, Behr M, Wu L, Yang W, Zhang L, and Ding X (2003) Liver-specific deletion of the NADPH-cytochrome P450 reductase gene: impact on plasma cholesterol homeostasis and the function and regulation of microsomal cytochrome P450 and heme oxygenase. J Biol Chem 278:25895-25901.
66. Henderson CJ, Otto DM, Carrie D, Magnuson MA, McLaren AW, Rosewell I, and Wolf CR (2003) Inactivation of the hepatic cytochrome P450 system by conditional deletion of hepatic cytochrome P450 reductase. J Biol Chem 278:13480-13486.
67. Kalsotra A, Turman CM, Kikuta Y, and Strobel HW (2004) Expression and characterization of human cytochrome P450 4F11: Putative role in the metabolism of therapeutic drugs and eicosanoids. Toxicol Appl Pharmacol 199:295-304.
68. Das A, Zhao J, Schatz GC, Sligar SG, and Van Duyne RP (2009) Screening of type I and II drug binding to human cytochrome P450-3A4 in nanodiscs by localized surface plasmon resonance spectroscopy. Anal Chem 81:3754-3759.
69. Schenkman JB, Remmer H, and Estabrook RW (1967) Spectral studies of drug interaction with hepatic microsomal cytochrome P-450. Mol Pharmaco 3:113-123.
70. Veith H, Southall N, Huang R, James T, Fayne D, Artemenko N, Shen M, Inglese J, Austin CP, Lloyd DG, et al. (2009) Comprehensive characterization of cytochrome P450 isozyme selectivity across chemical libraries. Nat Biotechnol 27:1050-1055.
71. Guengerich FP (2009) Cataloging the repertoire of nature's blowtorch, P450. Chem Biol 16:1215-1216.
72. Wu Z-L, Sohl CD, Shimada T, and Guengerich FP (2006) Recombinant enzymes over-expressed in bacteria show broad catalytic specificity of human cytochrome P450 2W1 and limited activity of human cytochrome P450 2S1. Mol Pharmacol 69:2007-2014.
73. Karlgren M, Gomez A, Stark K, Svard J, Rodriguez-Antona C, Oliw E, Bernal ML, Ramón y Cajal S, Johansson I, and Ingelman-Sundberg M (2006) Tumor-specific expression of the novel cytochrome P450 enzyme, CYP2W1. Biochem Biophys Res Commun 341:451-458.
74. Rylander T, Neve EPA, Ingelman-Sundberg M, and Oscarson M (2001) Identification and tissue distribution of the novel human cytochrome P450 2S1 (CYP2S1). Biochem Biophys Res Commun 281:529-535. (Pubitemid 32928187)
75. Rivera SP, Wang F, Saarikoski ST, Taylor RT, Chapman B, Zhang R, and Hankinson O (2007) A novel promoter element containing multiple overlapping xenobiotic and hypoxia response elements mediates induction of cytochrome P450 2S1 by both dioxin and hypoxia. J Biol Chem 282:10881-10893.
76. Smith G, Wolf CR, Deeni YY, Dawe RS, Evans AT, Comrie MM, Ferguson J, and Ibbotson SH (2003) Cutaneous expression of cytochrome P450 CYP2S1: Individuality in regulation by therapeutic agents for psoriasis and other skin diseases. Lancet 361:1336-1343.
77. Karlgren M, Miura S, and Ingelman-Sundberg M (2005) Novel extrahepatic cytochrome P450s. Toxicol Appl Pharmacol 207:57-61.
78. Bui PH and Hankinson O (2009) Functional characterization of human cytochrome P450 2S1 using a synthetic gene-expressed protein in Escherichia coli. Mol Pharmacol 76:1031-1043.
79. Kadlubar FF, Morton KC, and Ziegler DM.(1973) Microsomal-catalyzed hydroperoxide-dependent C-oxidation of amines. Biochem Biophys Res Commun 54:1255-1261.
80. Nordblom GD, White RE, and Coon MJ (1976) Studies on hydroperoxide- dependent substrate hydroxylation by purified liver microsomal cytochrome P-450. Arch Biochem Biophys 175:524-533.
81. Bui PH, Hsu EL, and Hankinson O (2009) Fatty acid hydroperoxides support cytochrome P450 2S1-mediated bioactivation of benzo[a]pyrene-7,8-dihydrodiol. Mol Pharmacol 76:1044-1052.
82. Wang T, Arifoglu P, Ronai Z, and Tew KD (2001) Glutathione S-transferase P1-1 (GSTP1-1) inhibits c-Jun N-terminal kinase (JNK1) signaling through interaction with the C terminus. J Biol Chem 276:20999-21003.
83. Ross D and Siegel D (2010) Quinone reductases, in Biotransformation (Guengerich, FP, ed.), Vol. 4 of Comprehensive Toxicology (McQueen, C.A., series ed.) Elsevier Science, New York, in press.
84. Stark K, Wu Z-L, Bartleson CJ, and Guengerich FP (2008) Heterologous expression and mRNA distribution of orphan cytochrome P450 20A1. Drug Metab Dispos 36:1930-1937.
85. Wu Z-L, Bartleson CJ, Ham A-J, and Guengerich FP (2006) Heterologous expression, purification, and properties of human cytochrome P450 27C1. Arch Biochem Biophys 445:138-146.
86. Cui X, Nelson DR, and Strobel HW (2000) A novel human cytochrome P450 4F isoform (CYP4F11): cDNA cloning, expression, and genomic structural characterization. Genomics 68:161-166.
87. Li A, Jiao X, Munier FL, Schorderet DF, Yao W, Iwata F, Hayakawa M, Kanai A, Shy Chen M, Lewis RA, et al. (2004) Bietti crystalline corneoretinal dystrophy is caused by mutations in the novel gene CYP4V2. Am J Hum Genet 74:817-826.
88. Rieger MA, Ebner R, Bell DR, Kiessling A, Rohayem J, Schmitz M, Temme A, Rieber EP, and Weigle B (2004) Identification of a novel mammary-restricted cytochrome P450, CYP4Z1, with overexpression in breast carcinoma. Cancer Res 64:2357-2364.